QC
ANIP icon

Quantedge Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Quantedge Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,000
Closed -$824K – 74
2025
Q3 		$824K Sell
9,000
-2,900
-24% -$236K 0.45% 37
2025
Q2 		$776K Buy
+11,900
New +$775K 0.71% 33
2024
Q4 		– Sell
-9,200
Closed -$549K – 134
2024
Q3 		$549K Sell
9,200
-12,000
-57% -$732K 0.16% 121
2024
Q2 		$1.35M Buy
+21,200
New +$1.38M 0.49% 60

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantedge Capital's ANIP Position: Q4 2025 in Review

Quantedge Capital sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 9,000 shares — an estimated $824K sold.

Quantedge Capital first reported a position in ANIP in Q2 2024 and held it in 4 quarters. The position peaked at $1.35M in Q2 2024. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Quantedge Capital reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quantedge Capital sold 9,000 ANI Pharmaceuticals shares in Q4 2025, an estimated $824K.
  • Quantedge Capital first reported a position in ANI Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Quantedge Capital's ANI Pharmaceuticals position peaked at $1.35M in Q2 2024.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Quantedge Capital's 13F filing for Q4 2025, filed 17 Feb 2026.